Manavata Oncology LLP ( LLP ), a subsidiary LLP of Healthcare Global Enterprises Limited ( Company ) has…
As filed · Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ), we would like to inform that HCG Manavata Oncology LLP ( LLP ),
What happened
FactHealthCare Global Enterprises Limited's subsidiary, HCG Manavata Oncology LLP, has entered into an agreement to acquire a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited for an aggregate consideration of INR 38 lakh. Following this acquisition, the Company will have an indirect interest of up to 26% in EVRE. Further details are available on the Company's website.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
Scale
- 0.0% of FY26 revenue
₹38 Lakh stated in the filing against ₹1,365.3 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Order Book
RevisedThe bucket with more than INR10 crore per month revenue we have got from last year 4 hospitals, we moved to 7 hospitals.
The bucket with INR5 crore to INR10 crore per month revenue, that number has gone down from 14 to 11.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- As they inch closer towards the EBITDA margin of the established centers, we expect our EBITDA margins to impr (management committed by FY26)
- In line with our commitment to cutting-edge diagnosis and research, we are pleased to share that we are acquir (management committed by FY26)
Evidence
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%